期刊文献+

甲基化结合蛋白2和组蛋白去乙酰化酶6在人瘢痕组织中的表达 被引量:2

The different expression and significance of methyl CpG binding protein 2 and histone deacetylase 6 in human scar formation
原文传递
导出
摘要 目的研究在人不同瘢痕组织及增生性瘢痕不同生长时期成纤维细胞中甲基化结合蛋白2(methyl CpG binding protein 2,MECP2)和组蛋白去乙酰化酶6(histone deacetylase 6,HDAC6)的表达及意义。方法收集2016年8月至2017年5月重庆医科大学附属第一医院烧伤整形科收治的118例瘢痕患者及33例上睑松弛患者的手术标本,包括正常皮肤33例(男12例,女性21例,年龄34~68岁);正常瘢痕32例(男19例,女13例,年龄8~68岁);瘢痕疙瘩35例(男11例,女24例,年龄11~62岁);增生性瘢痕51例(男22例,女29例,12~58岁)。其中增生性瘢痕根据生长时间分为4组:0~3个月组10例、4~6个月组11例、7~12个月组13例、>12个月组17例。采用免疫组织化学及蛋白质印迹法检测各组组织中MECP2及HDAC6的表达情况,实时定量聚合酶链反应技术检测各组组织中MECP2 mRNA和HDAC6 mRNA的表达,并比较各组之间的差异。实验所得数据用SPSS 20.0进行统计学分析,各组之间的差异采用单因素方差分析进行检验,2组间比较采用t检验,P<0.05为差异有统计学意义。结果免疫组织化学结果显示,MECP2在正常皮肤成纤维细胞中表达呈阴性或弱阳性,在正常瘢痕中表达呈弱阳性,在增生性瘢痕中表达呈阳性,在瘢痕疙瘩成纤维细胞核内大量表达。MECP2蛋白在正常皮肤(1326.4±572.3)、正常瘢痕(2341.4±816.2)、增生性瘢痕(3500.7±1407.6)、瘢痕疙瘩(4787.9±1514.3)中的表达逐渐增加(F=33.820,P=0.001);同样MECP2 mRNA在正常皮肤(0.82±0.43)、正常瘢痕(1.14±0.45)、增生性瘢痕(1.59±0.39)、瘢痕疙瘩(2.14±0.53)中的表达也是逐渐增加(F=23.400,P=0.001)。在正常皮肤(1332.5±746.7)、正常瘢痕(2307.7±1027.4)、增生性瘢痕(4107.4±1223.1)、瘢痕疙瘩(5155.9±1265.3)中HDAC6蛋白的表达差异有统计学意义(F=50.270,P=0.001);HDAC6 mRNA在正常皮肤(0.57±0.23)、正常瘢痕(1.03±0.35)、增生性瘢痕(1.47±0.31)、瘢痕疙瘩(1.87±0.45)中的表达差异有统计 Objective To investigate the expression and significance of fibroblasts methyl CpG binding protein 2(MECP2)and histone deacetylase 6(HDAC6)at different stages of scar tissues and hypertrophic scars.Methods From August 2016 to May 2017,118 cases of scar and 33 cases of upper eyelid lasia received from the Department of Plastic and Burn Surgery of the First Affiliated Hospital of Chongqing Medical University,Chongqing were collected,including 33 cases of normal skin(ages 34-68,12 cases of male and 21 cases of female),32 cases of normal scar(ages 8-68,19 cases of male and 13 cases of female),35 cases of keloid(ages 11-62,11 cases of male and 24 cases of female)and 51 cases of hypertrophic scar(ages 12-58,22 cases of male and 29 cases of female)without any treatment.The hypertrophic scar was divided into 4 groups according to the growth time:10 cases in the 0-3 month group,11 cases in the 4-6 month group,13 cases in the 7-12 month group,and 17 cases in the>12 month group.Immunohistochemistry and western blot were used to detect the expressions of MECP2 and HDAC6 in tissues of each group,and real-time quantitative polymerase chain reaction gene amplification fluorescence detection technology was used to detect the expressions of MECP2mRNA and HDAC6 mRNA,and the differences between each group were compared.SPSS20.0 was used for statistical analysis of the data obtained in the experiment,and one-way ANOVAwas used to test the differences between the groups.P<0.05 was considered statistically significant.Results MECP2 protein is gradually expressed in normal skin(1326.4±572.3),normal scar(2341.4±816.2),hypertrophic scar(3500.7±1407.6)and keloid(4787.9±1514.3),F=33.82,P=0.001.Similarly,the expression of MECP2mRNA in normal skin(0.82±0.43),normal scar(1v14±0.45),hypertrophic scar(1.59±0.39)and keloid(2.14±0.53)was also gradually increased,F=23.4,P=0.001.In normal skin(1332.5±746.7)and normal scar(2307.7±1027.4),hypertrophic scar(4107.4±1223.1)and keloid,the level of HDAC6 protein expression(5155.9±1265.3)were si
作者 黎丹 赵娟 杨娥 张恒术 Li Dan;Zhao Juan;Yang E;Zhang Hengshu(Department of Plastic and Burn Surgery,First Affiliated Hospital of Chongqing Medical University,Chongqing,400016,China)
出处 《中华整形外科杂志》 CAS CSCD 北大核心 2019年第10期1019-1026,共8页 Chinese Journal of Plastic Surgery
关键词 甲基化结合蛋白2 组蛋白去乙酰化酶6 瘢痕 纤维化 表观遗传学 Methyl CpG binding protein 2 Histone deacetylase 6 Scar Fibrosis Epigenetics
  • 相关文献

参考文献2

二级参考文献32

  • 1Zunwen L, Shizhen Z, Dewu L, et al. Effect of tetrandrine on the TGF-b-induced smad signal transduction pathway in human hypertrophic scar fibroblasts in vitro. B urns, 2012,38 : 404 -413. 被引量:1
  • 2Wolfram D, Tzankov A, Pulzl P, et al. Hypertrophic scars and keloids-a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg,2009, 35 : 171-181. 被引量:1
  • 3Niessen FB, Spauwen PH, Schalkwijk J, et al. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg, 1999, 104: 1435-1458. 被引量:1
  • 4Bran GM, Goessler UR, Baftiri A, et al. Effect of transforming growth factor-betal antisense oligonucleotides on matrix metalloproteinases and their inhibitors in keloid fibroblasts. Otolaryngol Head Neck Surg, 2010,143:66-71. 被引量:1
  • 5Massague J, Wotton D. Transcriptional control by the TGF-beta/ Smad signaling system. Embo J,2000,19 : 1745-1754. 被引量:1
  • 6Heldin CH, Landstrom M, Moustakas A. Mechanism of TGF- beta signaling to growth arrest, apoptosis, and epithelial- mesenchymal transition. Curr Opin Cell Biol,2009,21:166-176. 被引量:1
  • 7Oki Y,AnKI E ,ISSA JP,et al. Becltabine-bedside to bench . Crit Rev Oncol Hematol,2007,6! : 140-152. 被引量:1
  • 8Van der Veer WM, Bloemen MC, Ulrich MM, et al. Potential cellular and molecular causes of hypertrophic scar formation. Burns,2009,35:15-29. 被引量:1
  • 9Slemp AK, Kirschner RE. Keloids and scars:a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr,2006 ,18 :396-402. 被引量:1
  • 10Hsu YC,Chen MJ,Yu YM,et al, Suppression of TGF-bl/SMAD pathway and extracellular matrix production in primary keloid fibroblasts by curcuminoids: its potential therapeutic use in the chemoprevention of keloid. Arch Dermatol Res, 2010,302:717- 724. 被引量:1

共引文献11

同被引文献12

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部